Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 44 Neoplasm Metastasis 19 Liver Neoplasms 18 Colorectal Neoplasms 15 Cholangiocarcinoma 11 Pancreatic Neoplasms 9 Lung Neoplasms 9 Colonic Neoplasms 9 Breast Neoplasms 8 Carcinoma, Renal Cell 7 Carcinoma, Non-Small-Cell Lung 7 Barrett Esophagus 7 Thyroid Nodule 6 Recurrence 6 Rectal Neoplasms 6 Thyroid Neoplasms 5 Pain 4 Neoplasms 4 Kidney Neoplasms 4 Esophageal Neoplasms 4 Thyroid Cancer, Papillary 3 Prostatic Neoplasms 3 Leiomyoma 3 Biliary Tract Neoplasms 3 Bile Duct Neoplasms 3 Agnosia 3 Thyroid Diseases 2 Hyperaldosteronism 2 Hepatitis B 2 Gallbladder Neoplasms 2

Interventions

Gemcitabine 6 Cisplatin 6 Capecitabine 6 Liver Transplantation 4 Fluorouracil 4 Specimen Handling 3 Radiosurgery 3 Oxaliplatin 3 Magnetic Resonance Spectroscopy 3 toripalimab 2 dehydroftorafur 2 Self Expandable Metallic Stents 2 Platinum 2 Leucovorin 2 Biopsy 2 3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide 2 1,2-diaminocyclohexaneplatinum II citrate 2 trisacryl gelatin microspheres 1 tremelimumab 1 trametinib 1 tislelizumab 1 temoporfin 1 sacituzumab govitecan 1 ricolinostat 1 pembrolizumab 1 lenvatinib 1 gemcitabine-oxaliplatin regimen 1 fludarabine 1 durvalumab 1 binimetinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Klatskin Tumor × Radiofrequency Ablation × Clear all

NCT05551299 2025-03-27

CARP

University of Leipzig

Phase 4 Recruiting

Gastrointestinal

Bile Duct Neoplasms, Klatskin Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡